Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-20

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved Padagis Israel Pharmaceuticals Ltd's Nystatin and Triamcinolone Acetonide as an Original Application (ANDA) for a topical antifungal with anti-infl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)